Drug-eluting stents for the treatment of vertebral artery origin stenosis

Journal of Endovascular Therapy

Volumn 17, Issue 2, 2010, Pages 232-240

  Werner, Martin ^a   Bräunlich, Sven ^a   Ulrich, Matthias ^a   Bausback, Yvonne ^a   Schuster, Johannes ^a   Lukhaup, Anina ^a   Botsios, Spiridon ^a   Scheinert, Dierk ^a,b   Schmidt, Andrej ^a,b  

^a Park Hospital Leipzig   (Germany)

^b UNIVERSITY OF LEIPZIG HEART CENTER   (Germany)

Author keywords

Bare metal stent; Drug eluting stent; Restenosis; Stent compression; Stent kinking; Vertebral artery origin stenosis

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PACLITAXEL; TUBULIN MODULATOR;

ANGIOGRAPHY; ARTERY OCCLUSION; ARTICLE; CLINICAL ARTICLE; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; HYPERPLASIA; IMPLANTATION; MALE; PRIORITY JOURNAL; RADIOGRAPHY; RESTENOSIS; SUBCLAVIAN ARTERY; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VERTEBRAL ARTERY STENOSIS; AGED; ANGIOPLASTY; COHORT ANALYSIS; GRAFT OCCLUSION; RETROSPECTIVE STUDY; STROKE; VERTEBROBASILAR INSUFFICIENCY;

AGED; ANGIOPLASTY; COHORT STUDIES; DRUG-ELUTING STENTS; FEMALE; GRAFT OCCLUSION, VASCULAR; HUMANS; MALE; PACLITAXEL; RETROSPECTIVE STUDIES; STROKE; TREATMENT OUTCOME; TUBULIN MODULATORS; VERTEBROBASILAR INSUFFICIENCY;

EID: 77955507355     PISSN: 15266028     EISSN: 15451550     Source Type: Journal    
DOI: 10.1583/09-2904.1     Document Type: Article

References (33)

1. Wityk RJ, Chang HM, Rosengart A, et al. Proximal extracranial vertebral artery disease in the New England Medical Center Posterior Circulation Registry. Arch Neurol. 1998;55:470-478. (Pubitemid 28182692)
2. Moufarrij NA, Little JR, Furlan AJ, et al. Vertebral artery stenosis: long-term follow-up. Stroke. 1984;15:260-263. (Pubitemid 14171257)
3. Eberhardt O, Naegele T, Raygrotzki S, et al. Stenting of vertebrobasilar arteries in symptomatic atherosclerotic disease and acute occlusion: case series and review of the literature. J Vasc Surg. 2006;43:1145-1154. (Pubitemid 43833485)
4. Chimowitz MI, Lynn MJ, Howlett-Smith H, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med. 2005;352:1305-1316.
5. Coert BA, Chang SD, Marks MP, et al. Revascularization of the posterior circulation. Skull Base. 2005;15:43-62.
6. Hopkins LN, Budny JL. Complications of intracranial bypass for vertebrobasilar insufficiency. J Neurosurg. 1989;70:207-211.
7. Lin YH, Juang JM, Jeng JS, et al. Symptomatic ostial vertebral artery stenosis treated with tubular coronary stents: clinical results and restenosis analysis. J Endovasc Ther. 2004;11:719-726.
8. Yu SC, Leung TW, Lam JS, et al. Symptomatic ostial vertebral artery stenosis: treatment with drug-eluting stents-clinical and angiographic results at 1-year follow-up. Radiology. 2009;251:224-232.
9. Motarjeme A. Percutaneous transluminal angioplasty of supra-aortic vessels. J Endovasc Surg. 1996;3:171-181. (Pubitemid 26179352)
10. Mukherjee D, Pineda G. Extracranial vertebral artery intervention. J Interv Cardiol. 2007;20:409-416.
11. Taylor RA, Siddiq F, Suri MF, et al. Risk factors for in-stent restenosis after vertebral ostium stenting. J Endovasc Ther. 2008;15:203-212. (Pubitemid 351628573)
12. Stone GW, Ellis SG, Cox DA, et al. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial. Circulation. 2004;109:1942-1947.
13. Abou-Chebl A, Bashir Q, Yadav JS. Drug-eluting stents for the treatment of intracranial atherosclerosis: initial experience and midterm angiographic follow-up. Stroke. 2005;36:e165-168.
14. Gupta R, Al-Ali F, Thomas AJ, et al. Safety, feasibility, and short-term follow-up of drug-eluting stent placement in the intracranial and extracranial circulation. Stroke. 2006;37:2562-2566. (Pubitemid 44454680)
15. Seifert T, Augustin M, Klein GE, et al. Symptomatic stenosis of the vertebrobasilar arteries: results of extra- and intracranial stent-PTA. Eur J Neurol. 2009;16:31-36.
16. Lugmayr H, Kastner M, Frohler W, et al. Sirolimus-eluting stents for the treatment of symptomatic extracranial vertebral artery stenoses: early experience and 6-month follow-up. Rofo. 2004;176:1431-1435. (Pubitemid 39382288)
17. Ko YG, Park S, Kim JY, et al. Percutaneous interventional treatment of extracranial vertebral artery stenosis with coronary stents. Yonsei Med J. 2004;45:629-634. (Pubitemid 39263985)
18. Akins PT, Kerber CW, Pakbaz RS. Stenting of vertebral artery origin atherosclerosis in highrisk patients: bare or coated? A single-center consecutive case series. J Invasive Cardiol. 2008;20:14-20.
19. Edgell RC, Yavagal DR, Drazin D, et al. Treatment of vertebral artery origin stenosis with anti-proliferative drug-eluting stents. J Neuroimaging. 2008 Nov 7.
20. Albuquerque FC, Fiorella D, Han P, et al. A reappraisal of angioplasty and stenting for the treatment of vertebral origin stenosis. Neurosurgery. 2003;53:607-614.
21. Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results. Stroke. 2004;35:1388-1392.
22. Mintz GS, Weissman NJ. Intravascular ultrasound in the drug-eluting stent era. J Am Coll Cardiol. 2006;48:421-429. (Pubitemid 44093940)
23. Lin YH, Hung CS, Tseng WY, et al. Safety and feasibility of drug-eluting stent implantation at vertebral artery origin: the first case series in Asians. J Formos Med Assoc. 2008;107:253-258.
24. Pfisterer M, Brunner-La Rocca HP, Buser PT, et al. Late clinical events after clopidogrel discontinuation limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol. 2006;48:2584-2591. (Pubitemid 44881238)
25. Grube E, Dawkins K, Guagliumi G, et al. TAXUS VI final 5-year results: a multicentre, randomised trial comparing polymer-based moderate-release paclitaxel-eluting stent with a bare metal stent for treatment of long, complex coronary artery lesions. EuroIntervention. 2009;4:572-577.
26. Grines CL, Bonow RO, Casey DE, et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation. 2007;115:813-818. (Pubitemid 46294748)
27. Misra S, Thatipelli MR, Howe PW, et al. Preliminary study of the use of drug-eluting stents in atherosclerotic renal artery stenoses 4 mm in diameter or smaller. J Vasc Interv Radiol. 2008;19:833-839.
28. Bush RL, Najibi S, MacDonald MJ, et al. Endovascular revascularization of renal artery stenosis: technical and clinical results. J Vasc Surg. 2001;33:1041-1049. (Pubitemid 33586349)
29. Zampieri P, Colombo A, Almagor Y, et al. Results of coronary stenting of ostial lesions. Am J Cardiol. 1994;73:901-903. (Pubitemid 24158316)
30. Tsunoda T, Nakamura M, Wada M, et al. Chronic stent recoil plays an important role in restenosis of the right coronary ostium. Coron Artery Dis. 2004;15:39-44. (Pubitemid 39117998)
31. Tsutsumi M, Kazekawa K, Onizuka M, et al. Stent fracture in revascularization for symptomatic ostial vertebral artery stenosis. Neuroradiology. 2007;49:253-257. (Pubitemid 46332320)
32. Kim SR, Baik MW, Yoo SH, et al. Stent fracture and restenosis after placement of a drug-eluting device in the vertebral artery origin and treatment with the stent-in-stent technique. Report of two cases. J Neurosurg. 2007;106:907-911.
33. Lin YH, Liu YC, Tseng WY, et al. The impact of lesion length on angiographic restenosis after vertebral artery origin stenting. Eur J Vasc Endovasc Surg. 2006;32:379-385.